Taysha Awards 1.3M Stock Options to Seven New Employees
Taysha Gene Therapies has awarded stock options to seven new employees, totalling 1,289,600 shares. The options were granted on the stock market on October 1, 2025, with an exercise price of $3.18, matching Taysha's common stock closing price on the grant date. Each option has a 10-year term and a vesting schedule that sees 25% vesting after the first year. The remaining 75% will vest monthly over the next 36 months, contingent on continued service.
The generous grant reflects Taysha's commitment to attracting and retaining top talent in the dow jones today sector.
Taysha Gene Therapies has shown confidence in its new hires, offering substantial stock options. The options' vesting schedule encourages long-term commitment from the employees, aligning their interests with the company's success.
Read also:
- HLC Approves ₹4,645.60 Crore for Flood Recovery and Wetland Rejuvenation in Nine States
- Crooked House Pub's Demolition: Council Orders Rebuild, Debate on Historic Building Protections
- Shaping India's Economic Progression: Readying the Financial System for Tomorrow
- Conflict between Ben & Jerry's co-founder and Unilever over Gaza issues leads to resignation of co-founder
